Related Experiment Video
Updated: Jun 27, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Beyond a consensus classification for idiopathic interstitial pneumonias: progress and controversies
Jeffrey L Myers1, Anna-Luise A Katzenstein
1Departments of Pathology at University of Michigan School of Medicine, Ann Arbor, MI 48109-0054, USA. myerjeff@umich.edu
Histopathology
|December 5, 2008
Summary
Idiopathic interstitial pneumonias (IIPs) are classified using histopathology. Recent updates address controversies in IIP diagnosis, including nomenclature and the role of lung biopsy.
Area of Science:
- Pulmonology
- Pathology
- Histopathology
Background:
- Histopathological classification is crucial for differentiating idiopathic interstitial pneumonias (IIPs).
- A 2002 interdisciplinary classification system sparked debate regarding nomenclature and diagnostic roles.
- Understanding IIP subtypes is essential for appropriate clinical management.
Purpose of the Study:
- To provide an overview of the clinical and histological features of IIPs.
- To discuss recent developments and controversies in IIP classification and diagnosis.
- To highlight key areas of interest in the field of interstitial lung diseases.
Main Methods:
- Review of existing literature on idiopathic interstitial pneumonias.
- Analysis of histopathological features relevant to IIP classification.
- Discussion of controversies surrounding the 2002 classification system.
Main Results:
- Idiopathic interstitial pneumonias exhibit diverse clinical and histological presentations.
- The 2002 classification introduced challenges in nomenclature and diagnostic interpretation.
- Ongoing research continues to refine the understanding and classification of IIPs.
Conclusions:
- Accurate histopathological classification remains fundamental for managing IIPs.
- Addressing controversies in IIP diagnosis is vital for improving patient care.
- Continued research is necessary to advance the field of interstitial lung disease.
Related Concept Videos
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: